Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The pathogenic bacteria cell membrane refers broadly to the phospholipid bilayer that encloses all prokaryotic cells. In both Gram-positive and Gram-negative pathogenic bacteria, this structure serves as a selectively permeable barrier composed primarily of phospholipids interspersed with proteins. Its main functions include maintaining cellular integrity by controlling transport into/out of the cytoplasm; generating energy through processes like oxidative phosphorylation; supporting synthesis/secretion activities; mediating signal transduction; and providing anchorage for various enzymes involved in metabolism. In Gram-negative pathogens specifically, there are two distinct membranes—an inner/cytoplasmic one similar across most bacteria, plus an outer one containing lipopolysaccharide which contributes additional protection against host defenses. The unique features distinguishing bacterial from mammalian membranes make them attractive targets for certain antibiotics—most notably polymyxins—which disrupt their structure/function leading to rapid bactericidal activity. However, because “pathogenic bacteria cell membrane” does not refer to any single molecule but rather an essential structural component common across many species—and because it lacks specificity—it is best considered a general class rather than a canonical molecular target suitable for structured databases.
Drugs targeting the bacterial cell membranes act by: - Disrupting integrity/permeability of the lipid bilayer leading to leakage of cellular contents and rapid bactericidal effect.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Pathogenic bacteria cell membrane.